4//SEC Filing
Ferguson Toby 4
Accession 0001104659-25-080825
CIK 0001640266other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 2:09 PM ET
Size
5.1 KB
Accession
0001104659-25-080825
Insider Transaction Report
Form 4
Ferguson Toby
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-08-18$3.73/sh−19,000$70,870→ 138,914 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.79, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0002015616
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 2:09 PM ET
- Size
- 5.1 KB